Uetz-von Allmen E - Search Results

1

Antiganglioside GM1 antibodies and their complement activating capacity in central and peripheral nervous system disorders and in controls.

Uetz-von Allmen E, Sturzenegger M, Rieben R, Rihs F, Frauenfelder A, Nydegger UE. Uetz-von Allmen E, et al. Eur Neurol. 1998;39(2):103-10. doi: 10.1159/000007916. Eur Neurol. 1998. PMID: 9520071

2

Phenotype and functional analysis of human monocyte-derived dendritic cells loaded with biodegradable poly(lactide-co-glycolide) microspheres for immunotherapy.

Waeckerle-Men Y, Scandella E, Uetz-Von Allmen E, Ludewig B, Gillessen S, Merkle HP, Gander B, Groettrup M. Waeckerle-Men Y, et al. J Immunol Methods. 2004 Apr;287(1-2):109-24. doi: 10.1016/j.jim.2004.01.010. J Immunol Methods. 2004. PMID: 15099760

3

Dendritic cell-based multi-epitope immunotherapy of hormone-refractory prostate carcinoma.

Waeckerle-Men Y, Uetz-von Allmen E, Fopp M, von Moos R, Böhme C, Schmid HP, Ackermann D, Cerny T, Ludewig B, Groettrup M, Gillessen S. Waeckerle-Men Y, et al. Among authors: uetz von allmen e. Cancer Immunol Immunother. 2006 Dec;55(12):1524-33. doi: 10.1007/s00262-006-0157-3. Epub 2006 Apr 13. Cancer Immunol Immunother. 2006. PMID: 16612599 Free PMC article. Clinical Trial.

4

The preservation of phenotype and functionality of dendritic cells upon phagocytosis of polyelectrolyte-coated PLGA microparticles.

Fischer S, Uetz-von Allmen E, Waeckerle-Men Y, Groettrup M, Merkle HP, Gander B. Fischer S, et al. Among authors: uetz von allmen e. Biomaterials. 2007 Feb;28(6):994-1004. doi: 10.1016/j.biomaterials.2006.10.034. Epub 2006 Nov 21. Biomaterials. 2007. PMID: 17118442

5

CAL-1 as Cellular Model System to Study CCR7-Guided Human Dendritic Cell Migration.

Uetz-von Allmen E, Samson GPB, Purvanov V, Maeda T, Legler DF. Uetz-von Allmen E, et al. Front Immunol. 2021 Sep 16;12:702453. doi: 10.3389/fimmu.2021.702453. eCollection 2021. Front Immunol. 2021. PMID: 34603281 Free PMC article.

6

CCR7: roles in cancer cell dissemination, migration and metastasis formation.

Legler DF, Uetz-von Allmen E, Hauser MA. Legler DF, et al. Among authors: uetz von allmen e. Int J Biochem Cell Biol. 2014 Sep;54:78-82. doi: 10.1016/j.biocel.2014.07.002. Epub 2014 Jul 11. Int J Biochem Cell Biol. 2014. PMID: 25019368

7

Engineering of Nanobodies Recognizing the Human Chemokine Receptor CCR7.

Jakobs BD, Spannagel L, Purvanov V, Uetz-von Allmen E, Matti C, Legler DF. Jakobs BD, et al. Among authors: uetz von allmen e. Int J Mol Sci. 2019 May 27;20(10):2597. doi: 10.3390/ijms20102597. Int J Mol Sci. 2019. PMID: 31137829 Free PMC article.

8

Prostaglandin E2 at new glance: novel insights in functional diversity offer therapeutic chances.

Legler DF, Bruckner M, Uetz-von Allmen E, Krause P. Legler DF, et al. Among authors: uetz von allmen e. Int J Biochem Cell Biol. 2010 Feb;42(2):198-201. doi: 10.1016/j.biocel.2009.09.015. Epub 2009 Sep 27. Int J Biochem Cell Biol. 2010. PMID: 19788928 Review.

9

Loss of GM130 in breast cancer cells and its effects on cell migration, invasion and polarity.

Baschieri F, Uetz-von Allmen E, Legler DF, Farhan H. Baschieri F, et al. Among authors: uetz von allmen e. Cell Cycle. 2015;14(8):1139-47. doi: 10.1080/15384101.2015.1007771. Cell Cycle. 2015. PMID: 25892554 Free PMC article.

10

A unique signal sequence of the chemokine receptor CCR7 promotes package into COPII vesicles for efficient receptor trafficking.

Uetz-von Allmen E, Rippl AV, Farhan H, Legler DF. Uetz-von Allmen E, et al. J Leukoc Biol. 2018 Aug;104(2):375-389. doi: 10.1002/JLB.2VMA1217-492R. Epub 2018 Mar 30. J Leukoc Biol. 2018. PMID: 29603364

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

12 results

Search Page